Dibenzoylmethane is a novel inhibitor of eIF2a-P activity, targeting eIF2a-P-mediated translational repression prevent neurodegeneration in mice. References: Siskos MG, Choudhary MI, Gerothanassis IP. Refinement of labile hydrogen positions based on DFT calculations of (1)H NMR chemical shifts: comparison with X-ray and neutron diffraction methods. Org Biomol Chem. 2017 May 17. doi: 10.1039/c7ob01019b. [Epub ahead of print] PubMed PMID: 28513720.

纯度：≥98%

CAS：120-46-7